Author:
Muller Florian L.,Colla Simona,Aquilanti Elisa,Manzo Veronica E.,Genovese Giannicola,Lee Jaclyn,Eisenson Daniel,Narurkar Rujuta,Deng Pingna,Nezi Luigi,Lee Michelle A.,Hu Baoli,Hu Jian,Sahin Ergun,Ong Derrick,Fletcher-Sananikone Eliot,Ho Dennis,Kwong Lawrence,Brennan Cameron,Wang Y. Alan,Chin Lynda,DePinho Ronald A.
Publisher
Springer Science and Business Media LLC
Reference37 articles.
1. The Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455, 1061–1068 (2008)
2. Druker, B. J. Translation of the Philadelphia chromosome into therapy for CML. Blood 112, 4808–4817 (2008)
3. Guha, M. PARP inhibitors stumble in breast cancer. Nature Biotechnol. 29, 373–374 (2011)
4. De Soto, J. A. & Deng, C. X. PARP-1 inhibitors: are they the long-sought genetically specific drugs for BRCA1/2-associated breast cancers? Int. J. Med. Sci. 3, 117–123 (2006)
5. Weidle, U. H., Maisel, D. & Eick, D. Synthetic lethality-based targets for discovery of new cancer therapeutics. Cancer Genomics Proteomics 8, 159–171 (2011)
Cited by
289 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献